ArticleVaccines2023

Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.

Andrea Picchianti-Diamanti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.